Abstract
Rationale Bronchopulmonary dysplasia (BPD) is the most common morbidity affecting very preterm infants. Gut fungal and bacterial microbial communities contribute to multiple lung diseases and may influence BPD pathogenesis.
Methods We performed a prospective, observational cohort study comparing the multikingdom fecal microbiota of 144 preterm infants with or without moderate to severe BPD by sequencing the bacterial 16S and fungal ITS2 ribosomal RNA gene. To address the potential causative relationship between gut dysbiosis and BPD, we used fecal microbiota transplant in an antibiotic-pseudohumanized mouse model. Comparisons were made using RNA sequencing, confocal microscopy, lung morphometry, and oscillometry.
Results We analyzed 102 fecal microbiome samples collected during the second week of life. Infants who later developed BPD showed an obvious fungal dysbiosis as compared to infants without BPD (NoBPD, p = 0.0398, permutational multivariate ANOVA). Instead of fungal communities dominated by Candida and Saccharomyces, the microbiota of infants who developed BPD were characterized by a greater diversity of rarer fungi in less interconnected community architectures. On successful colonization, the gut microbiota from infants with BPD augmented lung injury in the offspring of recipient animals. We identified alterations in the murine intestinal microbiome and transcriptome associated with augmented lung injury.
Conclusions The gut fungal microbiome of infants who will develop BPD is dysbiotic and may contribute to disease pathogenesis.Conclusions: The gut fungal microbiome of infants who will develop BPD is dysbiotic and may contribute to disease pathogenesis.
Competing Interest Statement
CL is the founder of ResBiotic Nutrition, Inc. and Alveolus Bio, Inc. KW and NA are advisors.
Funding Statement
Research reported in this article was supported by the National Institutes of Health under award numbers K08 HL151907 (KW), L40 HL159581 (KW), KL2 TR3097 (VJ), K08 HL141652 (CVL), R01 HL156275 (NA), R01 HL129907 (NA), R21 DK129890K08 (JP), and R21 AI163503 (JP), the Dixon Fellowship (MS), the Microbiome Center of the University of Alabama at Birmingham (KW), and the Division of Neonatology at the University of Tennessee Health Science Center (AT).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Cohort 1: This study was approved by the Institutional Review Board of The University of Tennessee under protocol 17-05311-XP and conducted in accordance with the Declaration of Helsinki. Cohort 2: This study was approved under protocol IRB-300003994, by the IRB at the University of Alabama at Birmingham.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
We completely revised microbiome and mycobiome analyses.
Data Availability
All data produced in the present study are available upon reasonable request to the authors. Raw MiSeq and RNAseq data are deposited at the NCBI sequence read archive (BioProject: PRJNA982880). Processed data files and custom code are available at github.com/WillisLungLab/MiBPD
